{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:54:34Z","timestamp":1793332474712,"version":"4.5.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1038\/s41390-020-0792-y","type":"journal-article","created":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T12:02:28Z","timestamp":1580558548000},"page":"629-636","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Dose-escalation trial of budesonide in surfactant for prevention of bronchopulmonary dysplasia in extremely low gestational age high-risk newborns (SASSIE)"],"prefix":"10.1038","volume":"88","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8501-8813","authenticated-orcid":false,"given":"Cindy T.","family":"McEvoy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip L.","family":"Ballard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert M.","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph E.","family":"Rower","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajan","family":"Wadhawan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark L.","family":"Hudak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joern-Hendrik","family":"Weitkamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanette","family":"Asselin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryl","family":"Chapin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta A.","family":"Ballard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,1]]},"reference":[{"key":"792_CR1","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.jpeds.2018.01.043","volume":"197","author":"RD Higgins","year":"2018","unstructured":"Higgins, R. D. et al. Bronchopulmonary dysplasia: executive summary of a workshop. J. Pediatr. 197, 300\u2013308 (2018).","journal-title":"J. Pediatr."},{"issue":"Suppl 3","key":"792_CR2","doi-asserted-by":"publisher","first-page":"S146","DOI":"10.1513\/AnnalsATS.201312-424LD","volume":"11","author":"CT McEvoy","year":"2014","unstructured":"McEvoy, C. T. et al. Bronchopulmonary dysplasia: NHLBI Workshop on the Primary Prevention of Chronic Lung Diseases. Ann. Am. Thorac. Soc. 11(Suppl 3), S146\u2013S153 (2014).","journal-title":"Ann. Am. Thorac. Soc."},{"key":"792_CR3","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.jpeds.2017.04.026","volume":"187","author":"RL Keller","year":"2017","unstructured":"Keller, R. L. et al. Bronchopulmonary dysplasia and perinatal characteristics predict 1-year respiratory outcomes in newborns born at extremely low gestational age: a prospective cohort study. J. Pediatr. 187, 89\u201397 (2017).","journal-title":"J. Pediatr."},{"key":"792_CR4","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1053\/j.semperi.2018.09.013","volume":"42","author":"JLY Cheong","year":"2018","unstructured":"Cheong, J. L. Y. & Doyle, L. W. An update on pulmonary and neurodevelopmental outcomes of bronchopulmonary dysplasia. Semin. Perinatol. 42, 478\u2013484 (2018).","journal-title":"Semin. Perinatol."},{"key":"792_CR5","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1164\/ajrccm.163.7.2011060","volume":"163","author":"AH Jobe","year":"2001","unstructured":"Jobe, A. H. & Bancalari, E. Bronchopulmonary dysplasia. Am. J. Respir. Crit. Care Med. 163, 1723\u20131729 (2001).","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"2 Pt 1","key":"792_CR6","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1542\/peds.110.2.285","volume":"110","author":"BJ Stoll","year":"2002","unstructured":"Stoll, B. J. et al. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics 110(2 Pt 1), 285\u2013291 (2002).","journal-title":"Pediatrics"},{"key":"792_CR7","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1164\/rccm.201612-2414OC","volume":"196","author":"LA Morrow","year":"2017","unstructured":"Morrow, L. A. et al. Antenatal determinants of bronchopulmonary dysplasia and late respiratory disease in preterm infants. Am. J. Respir. Crit. Care Med. 196, 364\u2013374 (2017).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"792_CR8","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jpeds.2015.09.031","volume":"168","author":"RA Ballard","year":"2016","unstructured":"Ballard, R. A. et al. Randomized trial of late surfactant treatment in ventilated preterm infants receiving inhaled nitric oxide. J. Pediatr. 168, 23\u201329 (2016).","journal-title":"J. Pediatr."},{"key":"792_CR9","first-page":"CD001145","volume":"10","author":"LW Doyle","year":"2017","unstructured":"Doyle, L. W., Cheong, J. L., Ehrenkranz, R. A. & Halliday, H. L. Late (>7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants. Cochrane Database Syst. Rev. 10, CD001145 (2017).","journal-title":"Cochrane Database Syst. Rev."},{"key":"792_CR10","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.siny.2019.04.007","volume":"24","author":"O Baud","year":"2019","unstructured":"Baud, O. & Watterberg, K. L. Prophylactic postnatal corticosteroids: early hydrocortisone. Semin. Fetal Neonatal Med. 24, 202\u2013206 (2019).","journal-title":"Semin. Fetal Neonatal Med."},{"key":"792_CR11","first-page":"CD010941","volume":"1","author":"W Onland","year":"2017","unstructured":"Onland, W., De Jaegere, A. P., Offringa, M. & van Kaam, A. Systemic corticosteroid regimens for prevention of bronchopulmonary dysplasia in preterm infants. Cochrane Database Syst. Rev. 1, CD010941 (2017).","journal-title":"Cochrane Database Syst. Rev."},{"key":"792_CR12","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1159\/000286210","volume":"98","author":"LW Doyle","year":"2010","unstructured":"Doyle, L. W., Ehrenkranz, R. A. & Halliday, H. L. Dexamethasone treatment in the first week of life for preventing bronchopulmonary dysplasia in preterm infants: a systematic review. Neonatology 98, 217\u2013224 (2010).","journal-title":"Neonatology"},{"key":"792_CR13","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1056\/NEJM200101113440203","volume":"344","author":"AR Stark","year":"2001","unstructured":"Stark, A. R. et al. Adverse effects of early dexamethasone in extremely-low-birth-weight infants. National Institute of Child Health and Human Development Neonatal Research Network. N. Engl. J. Med. 344, 95\u2013101 (2001).","journal-title":"N. Engl. J. Med."},{"key":"792_CR14","first-page":"CD001146","volume":"10","author":"LW Doyle","year":"2017","unstructured":"Doyle, L. W., Cheong, J. L., Ehrenkranz, R. A. & Halliday, H. L. Early (<8 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants. Cochrane Database Syst. Rev. 10, CD001146 (2017).","journal-title":"Cochrane Database Syst. Rev."},{"key":"792_CR15","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.siny.2019.03.002","volume":"24","author":"JLY Cheong","year":"2019","unstructured":"Cheong, J. L. Y. & Doyle, L. W. Long-term effects of postnatal corticosteroids to prevent or treat bronchopulmonary dysplasia: balancing the risks and benefits. Semin. Fetal Neonatal Med. 24, 197\u2013201 (2019).","journal-title":"Semin. Fetal Neonatal Med."},{"key":"792_CR16","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1056\/NEJMoa1501917","volume":"373","author":"D Bassler","year":"2015","unstructured":"Bassler, D. et al. Early inhaled budesonide for the prevention of bronchopulmonary dysplasia. N. Engl. J. Med. 373, 1497\u20131506 (2015).","journal-title":"N. Engl. J. Med."},{"key":"792_CR17","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.jpeds.2009.10.049","volume":"156","author":"HT Kuo","year":"2010","unstructured":"Kuo, H. T., Lin, H. C., Tsai, C. H., Chouc, I. C. & Yeh, T. F. A follow-up study of preterm infants given budesonide using surfactant as a vehicle to prevent chronic lung disease in preterm infants. J. Pediatr. 156, 537\u2013541 (2010).","journal-title":"J. Pediatr."},{"key":"792_CR18","doi-asserted-by":"publisher","first-page":"e1310","DOI":"10.1542\/peds.2007-1973","volume":"121","author":"TF Yeh","year":"2008","unstructured":"Yeh, T. F. et al. Early intratracheal instillation of budesonide using surfactant as a vehicle to prevent chronic lung disease in preterm infants: a pilot study. Pediatrics 121, e1310\u2013e1318 (2008).","journal-title":"Pediatrics"},{"key":"792_CR19","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1164\/rccm.201505-0861OC","volume":"193","author":"TF Yeh","year":"2016","unstructured":"Yeh, T. F. et al. Intra-tracheal administration of budesonide\/surfactant to prevent bronchopulmonary dysplasia. Am. J. Respir. Crit. Care Med. 193, 86\u201395 (2016).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"792_CR20","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1165\/rcmb.2016-0068OC","volume":"55","author":"AM Barrette","year":"2016","unstructured":"Barrette, A. M. et al. Antiinflammatory effects of budesonide in human fetal lung. Am. J. Respir. Cell Mol. Biol. 55, 623\u2013632 (2016).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"792_CR21","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1089\/aid.2012.0089","volume":"29","author":"JR Castillo-Mancilla","year":"2013","unstructured":"Castillo-Mancilla, J. R. et al. Tenofovir, emtricitabine, and tenofovir diphosphate in dried blood spots for determining recent and cumulative drug exposure. AIDS Res. Hum. Retroviruses 29, 384\u2013390 (2013).","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"792_CR22","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.jpba.2019.01.048","volume":"167","author":"JE Rower","year":"2019","unstructured":"Rower, J. E. et al. Development and validation of an assay for quantifying budesonide in dried blood spots collected from extremely low gestational age neonates. J. Pharm. Biomed. Anal. 167, 7\u201314 (2019).","journal-title":"J. Pharm. Biomed. Anal."},{"key":"792_CR23","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.jpeds.2016.03.058","volume":"174","author":"CT D\u2019Angio","year":"2016","unstructured":"D\u2019Angio, C. T. et al. Blood cytokine profiles associated with distinct patterns of bronchopulmonary dysplasia among extremely low birth weight infants. J. Pediatr. 174, 45\u201351.e5 (2016).","journal-title":"J. Pediatr."},{"key":"792_CR24","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1373\/clinchem.2005.052241","volume":"51","author":"K Skogstrand","year":"2005","unstructured":"Skogstrand, K. et al. Simultaneous measurement of 25 inflammatory markers and neurotrophins in neonatal dried blood spots by immunoassay with xMAP technology. Clin. Chem. 51, 1854\u20131866 (2005).","journal-title":"Clin. Chem."},{"key":"792_CR25","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1038\/ng.3809","volume":"49","author":"T Long","year":"2017","unstructured":"Long, T. et al. Whole-genome sequencing identifies common-to-rare variants associated with human blood metabolites. Nat. Genet. 49, 568\u2013578 (2017).","journal-title":"Nat. Genet."},{"key":"792_CR26","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jpeds.2017.10.004","volume":"193","author":"LM Askie","year":"2018","unstructured":"Askie, L. M. et al. Race effects of inhaled nitric oxide in preterm infants: an individual participant data meta-analysis. J. Pediatr. 193, 34\u201339 (2018).","journal-title":"J. Pediatr."},{"key":"792_CR27","doi-asserted-by":"publisher","first-page":"L193","DOI":"10.1152\/ajplung.00528.2017","volume":"315","author":"TB Kothe","year":"2018","unstructured":"Kothe, T. B. et al. Effects of budesonide and surfactant in preterm fetal sheep. Am. J. Physiol. Lung Cell Mol. Physiol. 315, L193\u2013L201 (2018).","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"792_CR28","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1210\/jcem-41-2-290","volume":"41","author":"PL Ballard","year":"1975","unstructured":"Ballard, P. L., Carter, J. P., Graham, B. S. & Baxter, J. D. A radioreceptor assay for evaluation of the plasma glucocorticoid activity of natural and synthetic steroids in man. J. Clin. Endocrinol. Metab. 41, 290\u2013304 (1975).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"792_CR29","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1111\/j.1365-2265.1991.tb03564.x","volume":"35","author":"A Donaldson","year":"1991","unstructured":"Donaldson, A., Nicolini, U., Symes, E. K., Rodeck, C. H. & Tannirandorn, Y. Changes in concentrations of cortisol, dehydroepiandrosterone sulphate and progesterone in fetal and maternal serum during pregnancy. Clin. Endocrinol. 35, 447\u2013451 (1991).","journal-title":"Clin. Endocrinol."},{"key":"792_CR30","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/BF00195934","volume":"49","author":"RA Lugo","year":"1996","unstructured":"Lugo, R. A., Nahata, M. C., Menke, J. A. & McClead, R. E. Jr. Pharmacokinetics of dexamethasone in premature neonates. Eur. J. Clin. Pharm. 49, 477\u2013483 (1996).","journal-title":"Eur. J. Clin. Pharm."},{"key":"792_CR31","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1172\/JCI108236","volume":"56","author":"PL Ballard","year":"1975","unstructured":"Ballard, P. L., Granberg, P. & Ballard, R. A. Glucocorticoid levels in maternal and cord serum after prenatal betamethasone therapy to prevent respiratory distress syndrome. J. Clin. Invest. 56, 1548\u20131554 (1975).","journal-title":"J. Clin. Invest."},{"key":"792_CR32","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/jp.2010.210","volume":"31","author":"JD Merrill","year":"2011","unstructured":"Merrill, J. D. et al. Pilot trial of late booster doses of surfactant for ventilated premature infants. J. Perinatol. 31, 599\u2013606 (2011).","journal-title":"J. Perinatol."},{"key":"792_CR33","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1111\/j.1476-5381.1996.tb15442.x","volume":"118","author":"A van\u2019t Veen","year":"1996","unstructured":"van\u2019t Veen, A. et al. Exogenous pulmonary surfactant as a drug delivering agent: influence of antibiotics on surfactant activity. Br. J. Pharm. 118, 593\u2013598 (1996).","journal-title":"Br. J. Pharm."},{"key":"792_CR34","doi-asserted-by":"crossref","unstructured":"van\u2019t Veen, A. et al. Influence of pulmonary surfactant on in vitro bactericidal activities of amoxicillin, ceftazidime, and tobramycin. Antimicrob., Agent Chemother. 329\u2013333 (1995).","DOI":"10.1128\/AAC.39.2.329"}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41390-020-0792-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-020-0792-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-020-0792-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T05:44:39Z","timestamp":1744177479000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41390-020-0792-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,1]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["792"],"URL":"https:\/\/doi.org\/10.1038\/s41390-020-0792-y","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,1]]},"assertion":[{"value":"4 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}